Difference between revisions of "Perseus LLC"
Steve Doyon (talk | contribs) (SW: Updating information) |
(SW: upd contact info, add catgs) |
||
Line 1: | Line 1: | ||
− | ''' | + | '''Perseus LLC''' (''Perseus'') is a "merchant bank and private equity fund management company with offices in Washington, D.C. and New York City. Since its inception in 1994, Perseus has invested in a broad range of transactions from [[venture capital]] financings to [[leveraged buyout]]s and debt market investments. Perseus generally invests in companies in which it can participate in the company's strategic planning, operations and development and thereby add significant value to the investment. In particular, Perseus invests in companies that have the strategic characteristics described more fully below, i.e., proprietary intellectual property, powerful brands, unique content or a highly skilled work force."[http://207.19.194.179/intro.htm] |
Perseus and its affiliates manage five investment funds: | Perseus and its affiliates manage five investment funds: | ||
Line 34: | Line 34: | ||
*[[Brian W. Farr]], Controller | *[[Brian W. Farr]], Controller | ||
− | == Contact == | + | ==Contact details== |
− | |||
2099 Pennsylvania Avenue, N.W., 9th Floor<br> | 2099 Pennsylvania Avenue, N.W., 9th Floor<br> | ||
Washington, D.C. 20006<br> | Washington, D.C. 20006<br> | ||
− | + | Phone: (202) 452-0101<br> | |
− | Fax 202. | + | Fax: (202) 429-0588<br> |
+ | Email: info AT perseusllc.com<br> | ||
+ | Web: http://perseusllc.com/intro.htm<br> | ||
− | + | 1325 Avenue of the Americas, 25th Floor<br> | |
− | New York, NY | + | New York, NY 10019<br> |
− | + | Phone: (212) 651-6400<br> | |
− | Fax 212 | + | Fax: (212) 651-6399<br> |
− | + | ==Related SourceWatch articles== | |
+ | *[[banking]] | ||
+ | == External links == | ||
− | + | [[Category:Banking industry]][[Category:United States]] | |
− | |||
− | |||
− | |||
− | |||
− |
Revision as of 22:40, 31 December 2007
Perseus LLC (Perseus) is a "merchant bank and private equity fund management company with offices in Washington, D.C. and New York City. Since its inception in 1994, Perseus has invested in a broad range of transactions from venture capital financings to leveraged buyouts and debt market investments. Perseus generally invests in companies in which it can participate in the company's strategic planning, operations and development and thereby add significant value to the investment. In particular, Perseus invests in companies that have the strategic characteristics described more fully below, i.e., proprietary intellectual property, powerful brands, unique content or a highly skilled work force."[1]
Perseus and its affiliates manage five investment funds:
- Perseus 1996
- Perseus Capital, L.L.C. ("Perseus Capital")
- Perseus 2000, L.L.C. ("Perseus 2000")
- Perseus Acquisition/Recapitalization Fund, L.L.C. (the "Acquisition/Recap Fund")
- Perseus-Soros BioPharmaceutical Fund, L.P. (the "BioPharmaceutical Fund")
Leadership
- Frank H. Pearl, Chairman and Chief Executive Officer
- Richard Charles Albert Holbrooke, Vice Chairman
- James A. Johnson, Vice Chairman
- Other Perseus Biographies
- Lewis A. Lee Sachs, Vice Chairman
- John T. Schwieters, Vice Chairman
- Kenneth M. Socha, Senior Managing Director
- Philip J. Deutch, Managing Director
- William B. Ford, Managing Director
- John C. Fox, Managing Director
- Curtis A. Glovier, Managing Director
- Thomas G. Labrecque, Jr., Managing Director
- Ray E. Newton III, Managing Director
- Charles C. Moore, Managing Director
- Rajeev Garside, Vice President
- Lisa M. Schule, Vice President
- Richard J. Shin, Vice President
- Richard M. Fruzzetti, Associate
- Rodd J. Macklin, Chief Financial Officer
- Brian W. Farr, Controller
Contact details
2099 Pennsylvania Avenue, N.W., 9th Floor
Washington, D.C. 20006
Phone: (202) 452-0101
Fax: (202) 429-0588
Email: info AT perseusllc.com
Web: http://perseusllc.com/intro.htm
1325 Avenue of the Americas, 25th Floor
New York, NY 10019
Phone: (212) 651-6400
Fax: (212) 651-6399